Academic Journals Database
Disseminating quality controlled scientific knowledge

Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial

ADD TO MY LIST
 
Author(s): Ghorbani Ali | Jasemi-Zergani Farzad

Journal: Journal of Renal Injury Prevention
ISSN 2345-2781

Volume: 2;
Issue: 3;
Start page: 109;
Date: 2013;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: Arteriovenous fistula | Ticlopidine | Hemodialysis

ABSTRACT
Implication for health policy/practice/research/medical education:Primary arteriovenous fistula (AVF), failure remains a major problem for hemodialysis patients. Vascular access thrombosis prophylaxis needs to start early in the end-stage renal disease patient. Ticlopidine seems to be effective and safe for prevention of primary AVF failure in hemodialysis patients.
Save time & money - Smart Internet Solutions      Why do you need a reservation system?